As Biopharma M&A Grows, EY Says Keep An Eye On China

 
• By Joseph Haas
  
GLOBE Model expected to save up to $12bn over seven years. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business